Literature DB >> 9075257

Dopaminergic sensitization: implications for the pathogenesis of schizophrenia.

B Y Glenthøj1, R Hemmingsen.   

Abstract

1. Which transmitters are primarily or secondarily involved in the pathogenesis of schizophrenia has been extensively studied during the last years. This review concentrates on the two systems, that most constantly have been found dysfunctioning in patients; that are the dopaminergic and glutamatergic systems. 2. Numerous neuropathological defects have been found in schizophrenia, but it is as yet unknown which changes are causative and which reflect maladaptive reactions. 3. All findings, however, involve the cortico-striato-thalamo-cortical circuits, which are central for attention and information processing. 4. The article focuses on the consequence of transmitter dysfunction for perception and for the ability of the individual to adapt to a constantly changing environment. Both clinical and experimental studies point to a primary/early cortical defect involving the glutamatergic system, and to a later developed intermittent hyperactivity of the dopaminergic system superimposed on a basal hypodopaminergic state. 5. The authors have previously demonstrated, how it is possible to potentiate mesolimbic dopaminergic activity by intermittent electrical stimulations of the cells in the ventral tegmental area, and that influence on the central mesolimbic dopamine cells is essential for the strengthened neuroplastic response. A changed neuroplastic response to environmental stimulation due to dopaminergic sensitization can explain how an episodic, subcortical hyperactivity can act on a basic glutamatergic and dopaminergic hypofunction to produce psychotic symptoms. Based on our own and others clinical and experimental findings, the "filter" hypothesis for schizophrenia and the state-dependence of schizophrenic symptoms, the authors present a hypothesis for spontaneous mesolimbic dopaminergic sensitization and progressive evolution of psychosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075257     DOI: 10.1016/s0278-5846(96)00158-3

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Abnormalities in thalamo-cortical connections in patients with first-episode schizophrenia: a two-tensor tractography study.

Authors:  Hesham M Hamoda; A T Makhlouf; J Fitzsimmons; Y Rathi; N Makris; R I Mesholam-Gately; J D Wojcik; J Goldstein; R W McCarley; L J Seidman; M Kubicki; M E Shenton
Journal:  Brain Imaging Behav       Date:  2019-04       Impact factor: 3.978

Review 2.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 3.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

4.  Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.

Authors:  Alessandra Paparelli; Marta Di Forti; Paul D Morrison; Robin M Murray
Journal:  Front Behav Neurosci       Date:  2011-01-17       Impact factor: 3.558

5.  Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.

Authors:  M Lamelle; A Abi-Dargham
Journal:  Dialogues Clin Neurosci       Date:  2000-12       Impact factor: 5.986

6.  Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers.

Authors:  Kirsten Borup Bojesen; Kasper Aagaard Andersen; Sophie Nordahl Rasmussen; Lone Baandrup; Line Malmer Madsen; Birte Yding Glenthøj; Egill Rostrup; Brian Villumsen Broberg
Journal:  Front Psychiatry       Date:  2018-02-06       Impact factor: 4.157

7.  Psychosocial Stress, Epileptic-Like Symptoms and Psychotic Experiences.

Authors:  Petr Bob; Tereza Petraskova Touskova; Ondrej Pec; Jiri Raboch; Nash Boutros; Paul Lysaker
Journal:  Front Psychol       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.